METABOLISM OF BENCE JONES PROTEINS.

No abstract is available for this paper.

• Publication year

  1964

• Venue

  Journal of Clinical Investigation

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI104884PMID 14105221PMCID PMC289501
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BENCE JONES PROTEINEMIA.

  1964cited by this paper
• HETEROGENEITY OF MYELOMA PROTEINS.

  1963cited by this paper
• ANTIGENIC RELATIONSHIPS OF BENCE JONES PROTEINS, MYELOMA GLOBULINS, AND NORMAL HUMAN γ-GLOBULIN

  1963cited by this paper
• IN VIVO BEHAVIOR OF I-FIBRINOGEN.

  1963cited by this paper
• PURIFICATION, ANALYSIS AND PROPERTIES OF SOME BENCE-JONES PROTEINS.

  1963cited by this paper
• TWO TYPES OF γ-MYELOMA PROTEINS, β2A-MYELOMA PROTEINS, γ1-MACROGLOBULINS, AND BENCE JONES PROTEINS IDENTIFIED BY TWO GROUPS OF COMMON ANTIGENIC DETERMINANTS

  1963cited by this paper
• THE FATE OF INJECTED BENCE JONES PROTEIN

  1963cited by this paper
• TWO TYPES OF gamma-MYELOMA PROTEINS, beta(2A)-MYELOMA PROTEINS, gamma(1)-MACROGLOBULINS, AND BENCE JONES PROTEINS IDENTIFIED BY TWO GROUPS OF COMMON ANTIGENIC DETERMINANTS.

  1963cited by this paper
• Clinical and experimental metabolism of normal 6.6s gamma-globulin in normal subjects and in patients with macroglobulinemia and multiple myeloma.

  1963cited by this paper
• ENZYMATICALLY PRODUCED SUBUNITS OF PROTEINS FORMED BY PLASMA CELLS IN MICE

  1962cited by this paper
• The turnover and distribution of I-131-labeled myeloma and macroglobulin proteins.

  1962cited by this paper
• Further studies of the gamma-related proteins of normal urine.

  1962cited by this paper
• The nature of Bence-Jones proteins. Chemical similarities to polypetide chains of myeloma globulins and normal gamma-globulins.

  1962cited by this paper
• CLASSIFICATION OF MYELOMA PROTEINS, BENCE JONES PROTEINS, AND MACROGLOBULINS INTO TWO GROUPS ON THE BASIS OF COMMON ANTIGENIC CHARACTERS

  1962cited by this paper
• THE NATURE OF BENCE-JONES PROTEINS

  1962cited by this paper
• ENZYMATICALLY PRODUCED SUBUNITS OF PROTEINS FORMED BY PLASMA CELLS IN MICE

  1962cited by this paper
• The turnover and distribution of I-131-labeled myeloma and macroglobulin proteins.

  1962cited by this paper
• Plasma proteins and the gastrointestinal tract.

  1962cited by this paper
• On a γ-globulin of low molecular weight in normal human plasma and urine

  1961cited by this paper
• Comparison of Reduced Alkylated Derivatives of some Myeloma Globulins and Bence-Jones Proteins

  1961cited by this paper
• ANTIGENIC RELATIONSHIPS BETWEEN IMMUNE GLOBULINS AND CERTAIN RELATED PARAPROTEINS IN MAN

  1961cited by this paper
• Plasma Albumin Catabolism in Experimental Nephrosis

  1961cited by this paper
• Formation of Bence-Jones protein and myeloma protein in vitro by the plasma-cell tumour MPC-2.

  1961cited by this paper
• THE METABOLISM OF NORMAL PLASMA PROTEINS AND GAMMA-MYELOMA PROTEIN IN MICE BEARING PLASMA-CELL TUMORS.

  1961cited by this paper
• The heat precipitation of Bence-Jones proteins. I. Optimum conditions.

  1959cited by this paper
• The Nature and Rates of Excretion of Radioactive Breakdown Products of I131-Albumin in the Rabbit

  1959cited by this paper
• Physicochemical and immunologic studies of gamma globulins of normal human urine.

  1959cited by this paper
• Studies of iodoalbumin metabolism. I. A mathematical approach to the kinetics.

  1959cited by this paper
• Efficient Trace-labelling of Proteins with Iodine

  1958cited by this paper
• Biocolloids in normal human urine. II. Physicochemical and immunochemical characteristics.

  1958cited by this paper
• Radioisotope techniques in clinical research and diagnosis.

  1958cited by this paper
• Site of Catabolism of Serum Albumin

  1958cited by this paper
• Aberrations of protein metabolism in multiple myeloma; interrelationships of abnormal serum globulins and Bence-Jones proteins.

  1957cited by this paper
• Phagocytosis of heat-denatured human serum albumin labelled with 131I and its use as a means of investigating liver blood flow.

  1957cited by this paper
• THE BEHAVIOR OF I131‐LABELED PLASMA PROTEINS IN VIVO

  1957cited by this paper
• Incorporation of N15-L-aspartic acid into the abnormal serum and urine proteins of multiple myeloma; studies of the inter-relationship of these proteins.

  1957cited by this paper
• Behaviour of 14C- and 131I-labelled plasma proteins in the rat.

  1956cited by this paper
• Studies on the metabolism of plasma proteins in the nephrotic syndrome. I. Albumin, gamma-globulin and iron-binding globulin.

  1956cited by this paper
• The mechanism and significance of protein excretion by the normal kidney.

  1956cited by this paper
• The mechanism and significance of protein excretion by the normal kidney.

  1956cited by this paper
• Multiple‐myeloma proteins. III. The antigenic relationship of Bence Jones proteins to normal gamma‐globulin and multiple‐myeloma serum proteins

  1956cited by this paper
• Proteins in multiple myeloma. III. Origin of Bence-Jones protein.

  1955cited by this paper
• Tracer experiments with I131 labeled human serum albumin: distribution and degradation studies.

  1953cited by this paper
• Quantitative aspects of iodine metabolism in man.

  1952cited by this paper
• The turnover rate of serum albumin in man as measured by I131-tagged albumin.

  1951cited by this paper
• STUDIES ON THE METABOLISM OF PLASMA PROTEINS IN THE NEPHROTIC SYNDROME. y-GLOBULIN AND IRON-BINDING GLOBULIN1

  year unknowncited by this paper

• B Cell-Derived and Non-B Cell-Derived Free Light Chains: From Generation to Biological and Pathophysiological Roles

  2025cites this paper
• [Nephropathy associated with monoclonal immunoglobulins: From clonal expansion B to renal toxicity of pathological immunoglobulins].

  2022cites this paper
• Discovery of Potent Coumarin-Based Kinetic Stabilizers of Amyloidogenic Immunoglobulin Light Chains Using Structure-Based Design.

  2021cites this paper
• The Pathophysiology of Kidney Involvement in Multiple Myeloma and Monoclonal-Related Disorders

  2021cites this paper
• Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory

  2019cites this paper
• Immune activation in alpha-1 antitrypsin deficiency related and usual chronic obstructive pulmonary disease

  2018cites this paper
• Incomplete Refolding of Antibody Light Chains to Non-Native, Protease-Sensitive Conformations Leads to Aggregation: A Mechanism of Amyloidogenesis in Patients?

  2017cites this paper
• The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.

  2016cites this paper
• Serum Free Light Chain Analysis

  2016cites this paper
• The association of serum-free light-chain levels with markers of renal function

  2015cites this paper
• Chaînes légères libres : structure, pathogénicité, méthodes d’étude

  2015cites this paper
• N Latex FLC serum free light-chain assays in patients with renal impairment

  2014cites this paper
• Relation between bone mineral density and IL-17 serum levels in Serbian patients with early Rheumatoid arthritis

  2014cites this paper
• Polyclonal free light chains: promising new biomarkers in inflammatory disease

  2014cites this paper
• The biology of immunoglobulin free light chains in kidney disease: a study of Monoclonal and Polyclonal light chains

  2012influential citation
• Monoclonal gammopathy of undetermined significance: an update for nephrologists.

  2012cites this paper
• Free immunoglobulin light chain: its biology and implications in diseases.

  2011cites this paper
• The biology of immunoglobulin free light chains and kidney injury.

  2011cites this paper
• Serum free light chain analysis

  2010cites this paper
• Bence Jones proteinuria in benign monoclonal gammapathies. Incidence and characteristics.

  2009cites this paper
• Renal Clearance of Nanoparticles

  2009cites this paper
• Paraproteinemia, Bence‐Jones Proteinuria and Amyloidosis

  2009cites this paper
• Serum free light chain assessment in monoclonal gammopathy and kidney disease

  2009cites this paper
• Spectrum of monoclonal gammapathies in Andhra Pradesh

  2008cites this paper
• The evolving use of serum free light chain assays in haematology

  2008cites this paper
• An overview of monoclonal gammapathies

  2008cites this paper
• Renal clearance of quantum dots

  2007cites this paper
• [Interest and limit of a free light chain immunoassay in serum and urine for the diagnosis and the follow-up of monoclonal dysglobulinemia].

  2006cites this paper
• Structure and function of the kidney in multiple myeloma

  2004cites this paper
• Renal Diseases Associated With Multiple Myeloma and Related Plasma Cell Dyscrasias

  2004cites this paper
• Free immunoglobulin light‐chain serum levels in the follow‐up of patients with monoclonal gammopathies: Correlation with 24‐hr urinary light‐chain excretion

  2004influential citation
• Double Light-ChainDisease : A Case Report

  2004cites this paper
• Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.

  2003cites this paper
• T H E CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS* BY HANS

  2003cites this paper
• Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.

  2000cites this paper
• Urine Free Light Chains in SLE: Clonal Markers of B-Cell Activity and Potential Link to In Vivo Secreted IG

  2000cites this paper
• Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity.

  1999cites this paper
• Metabolism of amyloid proteins.

  1996cites this paper
• Protein and host factors implicated in the pathogenesis of light chain amyloidosis (AL amyloidosis)

  1995cites this paper
• A molecular model for self-assembly of amyloid fibrils: immunoglobulin light chains.

  1995cites this paper
• Experience with digoxin immune Fab (ovine) in patients with renal impairment.

  1991cites this paper
• Organ destructive effect of the light chains. Myeloma kidney

  1991cites this paper
• The effect of exercise on urinary excretion of different size proteins in patients with insulin-dependent diabetes mellitus.

  1990cites this paper
• Urinary excretion of kappa light chains in patients with diabetes mellitus.

  1990cites this paper
• Immunologic and pharmacologic concepts of monoclonal antibodies.

  1989cites this paper
• Management of myeloma kidney: an anti-light-chain approach.

  1987cites this paper
• Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.

  1987cites this paper
• Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.

  1986cites this paper
• Fibrinogen and fibrin: biochemistry and pathophysiology.

  1986cites this paper
• Urinary Excretion of Plasma Proteins in Diabetic Subjects: Increased Excretion of Kappa Light Chains in Diabetic Patients With and Without Proliferative Retinopathy

  1985cites this paper
• Light chain disease and massive proteinuria.

  1985cites this paper
• Analysis of serum free light chains by crossed immunoelectrophoresis: comparison with urinary light chains in light chain disease.

  1984cites this paper
• Tissue uptake and catabolic studies of 125I SS-B (La) injected into mice.

  1984cites this paper
• [Plasmapheresis treatment in multiple myeloma with kidney insufficiency].

  1983cites this paper
• Lambda-light-chain nephropathy with Fanconi's syndrome.

  1983cites this paper
• In vivo fate of 125I SS-B (La) injected into mice.

  1983cites this paper
• Serum‐free light chain analysis by crossed immunoelectrophoresis: Correlation with plasmapheresis in light chain disease nephropathy

  1983cites this paper
• Myeloma protein kinetics following chemotherapy.

  1982cites this paper
• Rapid renal clearance of immunoreactive canine plasma myoglobin.

  1982cites this paper
• Distal renal tubular acidosis in multiple myeloma.

  1981cites this paper
• Monoclonal immunoglobulin light chains in urine of patients with lymphoma.

  1980cites this paper
• Dialysis in the treatment of multiple myeloma.

  1980cites this paper
• Multiple myeloma.

  1980cites this paper
• Low molecular proteins in the urine of patients with systemic lupus erythematosus

  1980cites this paper
• Tubular proteinuria in myeloma

  1980cites this paper
• Monoclonal Immunoglobulins As Biomarkers Of Cancer

  1980cites this paper
• Effector Sites on Antibodies

  1979cites this paper
• Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.

  1979cites this paper
• Double light-chain disease: a case report.

  1979cites this paper
• RENAL FUNCTION IN PATIENTS WITH MULTIPLE MYELOMA

  1978cites this paper
• Massive proteinuria in light chain disease.

  1978cites this paper
• Biology, Clinical Patterns, and Treatment of Multiple Myeloma and Related Plasma–Cell Dyscrasias

  1978cites this paper
• Immunoquantitation of free light chain immunoglobulins: applications in multiple myeloma.

  1978cites this paper
• Bence Jones proteins and light chains of immunoglobulins. XV. Effect of corticosteroids on synthesis and excretion of Bence Jones protein.

  1978cites this paper
• Catabolism of rat beta2-microglobulin in the rat.

  1977cites this paper
• Monoclonal immunoglobulin and its related abnormalities in cases of plasma cell dyscrasia.

  1977cites this paper
• Renal handling of Zn-alpha2-glycoprotein as compared with that of albumin and the retinol-binding protein.

  1976cites this paper
• A Study on the Urinary Low Molecular Proteins

  1976cites this paper
• Bence jones proteins: nature, metabolism, detection and significance.

  1976cites this paper
• Bence-Jones proteins and light chains of immunoglobulins (first of two parts).

  1976cites this paper
• The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradative fragments D and E.

  1976cites this paper
• Bence-Jones proteins and light chains of immunoglobulins (first of two parts).

  1976cites this paper
• Catabolism of Plasma Proteins

  1976cites this paper
• Human myeloma IgG half-molecules. Catabolism and biological properties.

  1975cites this paper
• The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis.

  1975cites this paper
• ACUTE RENAL FAILURE IN MULTIPLE MYELOMA

  1975cites this paper
• A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

  1975cites this paper
• Renal Enzyme Proteolysis of L-Chain with “Amyloid” Formation and Altered L-Chain Metabolism in S.L.E.*

  1974cites this paper
• Renal removal of low molecular weight proteins in myeloma and renal transplant patients.

  1974cites this paper
• Complexes in plasma between light chain κ immunoglobulins and α1-antitrypsin respectively prealbumin

  1974cites this paper
• [Myeloma-kidney. II. Correlation of structure and function with special reference to acute renal failure (author's transl)].

  1974cites this paper
• Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins.

  1974cites this paper
• Complexes in plasma between light chain kappa immunoglobulins and alpha 1-antitrypsin respectively prealbumin.

  1974cites this paper
• The role of the kidney in the metabolism of plasma proteins.

  1974cites this paper
• Die Plasmocytomniere

  1974cites this paper
• Immunoglobulin disturbances and their clinical significance.

  1973cites this paper
• The relationship between L-chain synthesis and gamma-globulin production.

  1973cites this paper
• Amyloidosis and multiple myeloma. A reevaluation using a control population.

  1973cites this paper
• Recovery from acute renal failure in plasma cell leukemia.

  1973cites this paper
• METABOLIC STUDIES ON 125I‐LABELLED BETA‐TRACE PROTEIN, WITH SPECIAL REFERENCE TO SYNTHESIS WITHIN THE CENTRAL NERVOUS SYSTEM

  1973cites this paper